Melguizo Alonso, Consolación Author
Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study
- Jabalera Y.
- Garcia-Pinel B.
- Ortiz R.
- Iglesias G.
- Cabeza L.
- Prados J.
- Jimenez-Lopez C.
- Melguizo C.
Pharmaceutics - 1/8/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.421 (2019)
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
- Carrillo, E
- Marchal, JA
- Prados, J
- Melguizo, C
- Velez, C
- Arena, N
- Alvarez, L
- Serrano, S
- Aranega, A
Cellular and molecular biology (Noisy-le-Grand, France) - 1/12/1998
- JCR Quartile: Q3 (1998)
- JCR Impact Factor: 1.151 (2022)
- Category normalized Impact: 0.11 (1998)
- CiteScore: 2.5 (2020)
- Scopus
- ORCID
- Web of Science
Nutritional and functional assessment of haloarchaea and microalgae from the Andalusian shoreline: Promising functional foods with a high nutritional value
- Martínez R.
- García Beltrán A.
- Kapravelou G.
- Guzmán A.
- Lozano A.
- Gómez-Villegas P.
- León R.
- Vigara J.
- Galisteo M.
- Aranda P.
- López-Jurado M.
- Prados J.
- Melguizo C.
- Porres J.M.
Journal of Functional Foods - 1/5/2024
- CiteScore: 9.6 (2022)
- SJR: 0.894 (2022
- SNIP: 1.212 (2022
Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo
- Carrasco, Esther
- Juan Alvarez, Pablo
- Melguizo, Consolacion
- Prados, Jose
- Alvarez-Manzaneda, Enrique
- Chahboun, Rachid
- Messouri, Ibtissam
- Isabel Vazquez-Vazquez, Maria
- Aranega, Antonia
- Rodriguez-Serrano, Fernando
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 22/05/2014
- JCR Quartile: Q2 (2014)
- SJR Quartile: Q1
- JCR Impact Factor: 3.447 (2022)
- Category normalized Impact: 0.806 (2014)
- CiteScore: 9.8 (2020)
- SJR: 1.079 (2014
- SNIP: 1.66 (2014
- JCR 5-year Impact Factor: 3.946
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
Non-viral and viral vectors for gene therapy
- Boulaiz, H
- Marchal, JA
- Prados, J
- Melguizo, C
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 2/9/2005
- JCR Quartile: Q4 (2005)
- SJR Quartile: Q2
- JCR Impact Factor: 1.018 (2022)
- Category normalized Impact: 0.755 (2005)
- CiteScore: 2.5 (2020)
- SJR: 0.482 (2005
- SJR Categories: Medicine (miscellaneous) (Q2)
- Scopus
- ORCID
- Web of Science
New Gene Therapy Strategies for Cancer Treatment: A Review of Recent Patents
- Ortiz, Raul
- Melguizo, Consolacion
- Prados, Jose
- Alvarez, Pablo J.
- Caba, Octavio
- Rodriguez-Serrano, Fernando
- Hita, Fidel
- Aranega, Antonia
Recent Patents on Anti-Cancer Drug Discovery - 09/2012
- JCR Quartile: Q4 (2012)
- SJR Quartile: Q1
- JCR Impact Factor: 2.7 (2012)
- Category normalized Impact: 0.625 (2012)
- JCR 5-year Impact Factor: 2.475
- JCR Categories: ONCOLOGY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)
New gene therapy strategies for cancer treatment: A review of recent patents
- Ortiz, Raul
- Melguizo, Consolacion
- Prados, Jose
- Alvarez, Pablo J.
- Caba, Octavio
- Rodriguez-Serrano, Fernando
- Hita, Fidel
- Aranega, Antonia
- AttaUrRahman
- Zaman, K
Recent Patents on Anti-Cancer Drug Discovery - 22/09/2012
- JCR Quartile: Q4 (2012)
- JCR Impact Factor: 4.295 (2022)
- CiteScore: 4.3 (2019)
- SJR: 1.082 (2012
- SNIP: 0.823 (2012
- JCR 5-year Impact Factor: 2.909
- JCR Categories: PHARMACOLOGY & PHARMACY
- ORCID
- Web of Science
New gene therapy strategies for cancer treatment: A review of recent patents
- Ortiz R.
- Melguizo C.
- Prados J.
- Álvarez P.
- Caba O.
- Rodríguez-Serrano F.
- Hita F.
- Aránega A.
Recent Patents on Anti-Cancer Drug Discovery - 22/10/2012
- SJR Quartile: Q1
- JCR Impact Factor: 2.7 (2012)
- CiteScore: 5.1 (2020)
- SJR: 1.082 (2012
- SNIP: 0.822 (2012
- JCR 5-year Impact Factor: 2.475
- JCR Categories: ONCOLOGY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)
Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review
- Alba Ortigosa-Palomo
- Francisco Quiñonero
- Raul Ortiz
- Francisco Sarabia
- Jose Prados
- Consolación Melguizo
Marine Drugs - 1/3/2024
- Scopus
- ORCID
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents
- Cabeza L.
- Perazzoli G.
- Mesas C.
- Jiménez-Luna C.
- Prados J.
- Rama A.R.
- Melguizo C.
AAPS PHARMSCITECH - 1/7/2020
- JCR Impact Factor: 3.246 (2020)
- JCR 5-year Impact Factor: 3.473
- JCR Categories: PHARMACOLOGY & PHARMACY
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador